Ori Biotech raised €88M in a Series B round in Jan 2022. The company is based in London, UK. Investors in the round: Amadeus Capital Partners, Chimera Capital, Delin Ventures and 4 others. Data as of 6 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
